Showing results (131-140 of 323) with videos related to
Sort By:
Pageof 33
Japanese Journal of Clinical Oncology|December 4, 2012
Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in KoreaJi-Yeon Kim, Yu Jung Kim, Keun-Wook Lee, et al.BMC Cancer|April 9, 2014
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancerSung Hoon Sim, Mi-Hyun Kang, Yu Jung Kim, et al.Cancer Research and Treatment|September 4, 2020
Pilot study for the Psychometric Validation of the Sheffield Profile for Assessment and Referral to Care (SPARC) in Korean Cancer PatientsJung Hye Kwon, Sun Kyung Baek, Do Yeun Kim, et al.Journal of Korean Medical Science|July 22, 2014
Toxicity profile of temozolomide in the treatment of 300 malignant glioma patients in KoreaSo Hyun Bae, Min-Jung Park, Min Mi Lee, et al.Journal of Breast Cancer|December 30, 2017
Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective StudyJin Hyun Park, In Sil Choi, Ki Hwan Kim, et al.Chemistryopen|February 28, 2026
Phytochemical Profiling of the Halophyte Artemisia fukudo Makino and Its In Vitro Effects on Androgen-Related Pathways Associated With Benign Prostatic Hyperplasia and AlopeciaYun Na Kim, Jae Sun Lee, Min Gyu Park, et al.Oncology Reports|November 6, 2014
Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cellsSung Ung Moon, Mi Hyun Kang, Ji Hea Sung, et al.Cancer Research and Treatment|January 25, 2018
Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast CancerSoomin Ahn, Hyun Jeong Kim, Milim Kim, et al.European Journal of Cancer (Oxford, England : 1990)|July 24, 2021
A randomised phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapyIn Sil Choi, Ki Hwan Kim, Ju Hyun Lee, et al.The Oncologist|October 2, 2015
Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10-06)Su Jin Lee, Tae Min Kim, Yu Jung Kim, et al.Pageof 33